Showing results (71-80 of 92) with videos related to
Sort By:
Pageof 10
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.Nature Communications|May 4, 2022
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screenAlice Mac Kain, Ghizlane Maarifi, Sophie-Marie Aicher, et al.Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.Iscience|July 29, 2024
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, et al.Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.Science Translational Medicine|July 22, 2026
Complement augments antibody neutralization of SARS-CoV-2 variantsMartin Jungbauer-Groznica, Pierre Rosenbaum, Isabelle Staropoli, et al.Ebiomedicine|October 22, 2021
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective studyBlandine Monel, Delphine Planas, Ludivine Grzelak, et al.Science Translational Medicine|December 8, 2020
IgA dominates the early neutralizing antibody response to SARS-CoV-2Delphine Sterlin, Alexis Mathian, Makoto Miyara, et al.Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.Med (New York, N.Y.)|October 14, 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.Pageof 10